Conmed Corporation (CNMD) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Conmed Corporation (CNMD:NYSE), powered by AI.

Current Price
$34.57
P/E Ratio
22.8
Market Cap
1.1B
Sector
Healthcare
What is the Conmed Corporation stock price forecast?

Conmed Corporation is currently trading at $34.57. View real-time AI analysis on Alpha Lenz.

What is Conmed Corporation insider trading activity?

View the latest insider trading data for Conmed Corporation on Alpha Lenz.

What is Conmed Corporation's P/E ratio?

Conmed Corporation's P/E ratio is 22.8.

Conmed Corporation

NYSE · CNMD
$34.57+0.41(+1.20%)Pre-marketNYSE regular session 09:30–16:00 ET
Ask about Conmed Corporation's future dividend policy...
Alpha Chat Insight

Conmed Corporation trades at a P/E of 22.8 (fair value) with modest ROE of 4.7%.

Ask for details

Company Overview

Conmed Corporation is a global medical technology company specializing in the development and supply of surgical devices and equipment. Its primary function is to provide innovative surgical solutions in areas such as orthopedics, general surgery, gynecology, and gastroenterology. Conmed's product portfolio encompasses advanced surgical tools, including energy systems, minimally invasive instrumentation, and orthopedic surgical equipment. As a prominent player in the healthcare and medical devices industry, Conmed impacts the way surgical procedures are performed, emphasizing patient safety and improved clinical outcomes. Headquartered in Utica, New York, the company serves a diverse customer base that includes hospitals, surgical centers, and healthcare professionals worldwide. Conmed's commitment to research and development, alongside strategic acquisitions and partnerships, strengthens its position in the marketplace, ensuring that it continues to meet the evolving demands of modern surgical practices.

CEOMr. Patrick J. Beyer
SectorHealthcare
IndustryMedical Devices
Employees3,900

Company Statistics

FY 2025

Profile

$1.07BMarket Cap
$1.37BRevenue
0.00Shares Out
3,900Employees

Margins

54.59%Gross
12.84%EBITDA
7.46%Operating
5.17%Pre-Tax
3.42%Net

Valuation

22.80P/E
1.04P/B
0.78EV/Sales
10.58EV/EBITDA
7.11P/FCF

Growth (CAGR)

9.56%Rev 3Yr
9.77%Rev 5Yr
13.57%Op Inc 3Yr
17.40%Op Inc 5Yr
N/ANet Inc 3Yr
37.66%Net Inc 5Yr

Returns

2.03%ROA
4.72%ROE
4.41%ROIC

Financial Health

$40.82MCash & Cash Equivalents
$1.25BNet Debt
125.12%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Conmed Corporation (ticker: CNMD) is a company listed on NYSE in the Healthcare sector (Medical Devices). It has approximately 3,900 employees. Market cap is $1.1B.

The current price is $34.57 with a P/E ratio of 22.8x and P/B of 1.04x.

ROE is 4.72% and operating margin is 7.46%. Annual revenue is $1.4B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Conmed Corporation (CNMD) Stock Forecast 2026 $34.57 — Price, Financials & Analyst Targets | Alpha Lenz